rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-2-18
|
pubmed:abstractText |
Several lines of evidence suggest that the immune system may control HIV-1 replication, but that it could fail in the long term. Strategies aimed to elicit specific immune responses may enable patients to contain virus replication.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0269-9370
|
pubmed:author |
pubmed-author:ANRS 093 Study Group,
pubmed-author:AboulkerJean-PierreJP,
pubmed-author:Beumont-MauvielMariaM,
pubmed-author:DelfraissyJean-FrançoisJF,
pubmed-author:DurierChristineC,
pubmed-author:El HabibRaphaëlleR,
pubmed-author:Gahéry-SégardHanneH,
pubmed-author:GoujardCécileC,
pubmed-author:GuilletJean-GérardJG,
pubmed-author:LévyYvesY,
pubmed-author:LascauxAnne-SophieAS,
pubmed-author:MeiffrédyVincentV,
pubmed-author:RouziouxChristineC
|
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
279-86
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15718838-AIDS Vaccines,
pubmed-meshheading:15718838-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15718838-CD4-Positive T-Lymphocytes,
pubmed-meshheading:15718838-CD8-Positive T-Lymphocytes,
pubmed-meshheading:15718838-Cell Proliferation,
pubmed-meshheading:15718838-Combined Modality Therapy,
pubmed-meshheading:15718838-HIV Antigens,
pubmed-meshheading:15718838-HIV Infections,
pubmed-meshheading:15718838-HIV-1,
pubmed-meshheading:15718838-Humans,
pubmed-meshheading:15718838-Immunization,
pubmed-meshheading:15718838-Interferon-gamma,
pubmed-meshheading:15718838-Interleukin-2,
pubmed-meshheading:15718838-Lymphocyte Activation,
pubmed-meshheading:15718838-Treatment Outcome,
pubmed-meshheading:15718838-Vaccines, Attenuated,
pubmed-meshheading:15718838-Vaccines, Combined,
pubmed-meshheading:15718838-Viral Load,
pubmed-meshheading:15718838-Viral Vaccines
|
pubmed:year |
2005
|
pubmed:articleTitle |
Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients.
|
pubmed:affiliation |
Unité d'Immunologie Clinique, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, 94010 Créteil Cedex, Paris, France. yves.levy@hmn.ap-hop-paris.fr
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|